Poland· PL-100107189
Syntarpen
A cloxacillin product containing cloxacillinum, registered in Poland by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cloxacillin is registered in 8 of 19 countries.
Countries holding a registration under ATC J01CF02 (cloxacillin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Cloxacillin · ATC J01CF02
8 / 19 countries
- Canada
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Norwayprice
- Polandprice
- Sweden
Price per daily dose
What a daily dose of cloxacillin costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cloxacillin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- FI Finland$5.89
The record
At a glance
URPL (Poland)- Active substance
- Cloxacillinum
- Manufacturer
- Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- Country
- Poland (PL)
- ATC code
- J01CF02
- ATC class
- Cloxacillin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990928910
- gtin05909990928927
- gtin05904016013755
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for cloxacillin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cloxacillin · interactions on record
22 records
- 3 severe
- 17 moderate
- 2 minor
Most severe, free to view
- MethotrexateL01BA01severe
- MethotrexateL04AX03severe
- MethotrexatM01CX01severe
- Sodium picosulfateA06AB08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cloxacillin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCLOXACILINA IPS 1g POLVO PARA SOLUCION INYECTABLE EFGI P S Farma S.L.
- FinlandCloxacillin MacureMacure Healthcare Limited
- FranceCLOXACILLINE ARROW 500 mg, géluleARROW GENERIQUES
- CanadaCLOXACILLIN FOR INJECTIONSTERIMAX INC
- SwedenCloxacillin Macure 1 g Pulver till injektions-/infusionsvätska, lösningMacure Healthcare Limited
- NorwayCloxacillin NavamedicNavamedic ASA
- IcelandCloxacillin NavamedicNavamedic ASA
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Cyprus · Cloxacillin Remedica, Monoclox
- Denmark · Cloxacillin Macure, Cloxacillin Navamedic
- Estonia · Cloxacillin Auxilia
- Spain · Anaclosil, Cloxacilina Normon
- Finland · Cloxacillin Macure, Cloxacillin Navamedic
- France · Cloxacilline Arrow, Cloxacilline Biogaran
- Greece · Staphyclox
- Croatia · Monoclox
- Iceland · Cloxacillin Navamedic, Cloxacillin Xgx Pharma
- Norway · Cloxacillin Macure, Cloxacillin Navamedic
- Portugal · Cloxacilina Generis
- Sweden · Cloxacillin Macure, Cloxacillin Navamedic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/152db5f8-313e-41a2-a7c7-2dafb16aad51 GET /v1/drugs/152db5f8-313e-41a2-a7c7-2dafb16aad51?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "1 g",
"packaging": "05909990928910 ¦ Rp ¦ 18686\n1 fiol. 1 g proszku\n05909990928927 ¦ Rp ¦ Skasowane ¦ 18689\n20 fiol. s. subst\n05904016013755 ¦ Rp ¦ 167900\n10 fiol. 1 g proszku",
"substance": "Cloxacillinum natrium 1.047 g",
"common_name": "Cloxacillinum",
"pl_product_id": "100107189",
"pozwolenie_nr": "09289",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about cloxacillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.